| P50 | author | Kyung Ah Park | Q16173390 |
| | Won Taek Lee | Q61525439 |
| | Jong Eun Lee | Q38323530 |
| P2093 | author name string | Juhyun Song | |
| P2860 | cites work | Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes? | Q56049682 |
| | Regulation of NMDA receptors by tyrosine kinases and phosphatases | Q57083922 |
| | Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men | Q57414649 |
| | Adipokines and Risk of Type 2 Diabetes in Older Men | Q57416309 |
| | Reducing the global burden of stroke: INTERSTROKE | Q57688595 |
| | Insulin in central nervous system: more than just a peripheral hormone | Q21296648 |
| | Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 |
| | Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway | Q24290228 |
| | Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A | Q24290420 |
| | Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages | Q24290861 |
| | Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 |
| | APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function | Q24318702 |
| | Brain fuel metabolism, aging, and Alzheimer's disease | Q24625859 |
| | Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism | Q27332330 |
| | The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor | Q27748941 |
| | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
| | Incidence of dementia: does gender make a difference? | Q28205517 |
| | Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice | Q28252794 |
| | Effects of human growth hormone in men over 60 years old | Q28288413 |
| | The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 |
| | Disruption of adiponectin causes insulin resistance and neointimal formation | Q28589597 |
| | A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 |
| | Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 |
| | Extended longevity in mice lacking the insulin receptor in adipose tissue | Q29614549 |
| | Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias | Q29616292 |
| | IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice | Q29616382 |
| | Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 |
| | Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Q29619211 |
| | Adipocytokines: mediators linking adipose tissue, inflammation and immunity | Q29619393 |
| | Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? | Q29619535 |
| | Neurovascular regulation in the normal brain and in Alzheimer's disease | Q29619659 |
| | Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint | Q30396337 |
| | Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes | Q30435465 |
| | Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler | Q30473135 |
| | Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study | Q31017646 |
| | Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling | Q31056825 |
| | Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms | Q33312303 |
| | The metabolic syndrome | Q33569142 |
| | Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories | Q33679242 |
| | Adiponectin-mediated modulation of hypertrophic signals in the heart | Q33688678 |
| | Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms | Q33688706 |
| | Natural history and histological classification of atherosclerotic lesions: an update | Q33916781 |
| | Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension | Q33921066 |
| | Adiponectin: systemic contributor to insulin sensitivity | Q33966206 |
| | Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association | Q33967781 |
| | Cardiovascular risk factors and dementia | Q34013162 |
| | Insulin receptors and insulin action in the brain: review and clinical implications | Q34105422 |
| | 2012 Alzheimer's disease facts and figures | Q34260109 |
| | Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain | Q34282041 |
| | Adipokines: molecular links between obesity and atheroslcerosis | Q34384883 |
| | Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 |
| | A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin | Q59466687 |
| | A neuropsychological assessment of the effects of moderate marihuana use | Q69530164 |
| | 15-year longitudinal study of blood pressure and dementia | Q71021081 |
| | The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study | Q71588556 |
| | Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart | Q73396535 |
| | The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy | Q74432333 |
| | Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes | Q74661001 |
| | Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p | Q77829278 |
| | Association of hypoadiponectinemia with coronary artery disease in men | Q78780687 |
| | Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo | Q79792625 |
| | Expression of alpha2-macroglobulin, neutrophil elastase, and interleukin-1alpha differs in early-stage and late-stage atherosclerotic lesions in the arteries of the circle of Willis | Q80224814 |
| | Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis | Q80243791 |
| | Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques | Q81362707 |
| | Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis | Q81544381 |
| | Adiponectin inhibits hyperlipidemia-induced platelet aggregation via attenuating oxidative/nitrative stress | Q82650574 |
| | A crucial role for adipose tissue p53 in the regulation of insulin resistance | Q84491291 |
| | Hypertension and dementia | Q84933821 |
| | [Meta-analysis of the association between adiponectin gene +276g/T polymorphisms and coronary atherosclerotic heart disease] | Q85727243 |
| | Protective vascular and myocardial effects of adiponectin | Q37333656 |
| | Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre | Q37380546 |
| | Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study. | Q37404531 |
| | Adiponectin as a new paradigm for approaching Alzheimer's disease. | Q37420289 |
| | Adiponectin in insulin resistance: lessons from translational research | Q37474736 |
| | Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis | Q37603615 |
| | Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span | Q37670847 |
| | Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis | Q37857377 |
| | Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes | Q37930196 |
| | Adipokines and stroke: a review of the literature. | Q37940717 |
| | Dementia, stroke, and vascular risk factors; a review | Q37970511 |
| | Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies | Q37973959 |
| | Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. | Q38066233 |
| | The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 |
| | Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. | Q38105211 |
| | Adipocytokines and aging: adiponectin and leptin | Q38111608 |
| | Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | Q38361016 |
| | Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. | Q38501870 |
| | Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. | Q39674949 |
| | Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans | Q40210296 |
| | Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease | Q40287992 |
| | A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | Q40467498 |
| | C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women | Q40608305 |
| | A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. | Q40734688 |
| | Human growth hormone and human aging | Q40906146 |
| | Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo | Q42073600 |
| | Expression of adiponectin and adiponectin receptors in human pituitary gland and brain | Q42440150 |
| | Hypertension in mice lacking the gene for endothelial nitric oxide synthase | Q42478091 |
| | Reduced brain insulin-like growth factor I function during aging. | Q42492454 |
| | Regional cerebral blood flow abnormalities in nondemented patients with memory impairment | Q42675127 |
| | Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome | Q43144687 |
| | Regional cerebral blood flow and cerebrovascular reactivity in Alzheimer's disease and vascular dementia assessed by arterial spinlabeling magnetic resonance imaging. | Q43518797 |
| | Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis | Q43572177 |
| | Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys | Q43596028 |
| | Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion | Q43679381 |
| | Prevalence of dementia disorders in the oldest-old: an autopsy study. | Q43746409 |
| | Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes | Q43833539 |
| | Long-term cognitive impairment after first-ever ischemic stroke in young adults | Q43848057 |
| | Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes | Q43889672 |
| | Diabetes, impaired fasting glucose, and development of cognitive impairment in older women | Q43959470 |
| | Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans | Q44007232 |
| | A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome | Q44043262 |
| | Adiponectin and development of type 2 diabetes in the Pima Indian population | Q44061673 |
| | Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians | Q44159135 |
| | Insulin signaling in the central nervous system: learning to survive | Q36568898 |
| | Dementia: a global health priority - highlights from an ADI and World Health Organization report | Q36632816 |
| | Adiponectin and cardiovascular disease: response to therapeutic interventions. | Q36727352 |
| | Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain | Q36729379 |
| | Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project | Q36756703 |
| | Hypertension and cerebrovascular dysfunction | Q36777769 |
| | Molecular connexions between dementia and diabetes. | Q36837972 |
| | Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature | Q36946413 |
| | Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention | Q37071211 |
| | Role of mitochondrial dysfunction in insulin resistance | Q37097807 |
| | A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues | Q37147048 |
| | Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus | Q37215415 |
| | The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged | Q37280580 |
| | Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training | Q37319777 |
| | Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. | Q44398229 |
| | Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. | Q44453195 |
| | Neutrophil elastase in human atherosclerotic plaques: production by macrophages | Q44456362 |
| | Adiponectin stimulates production of nitric oxide in vascular endothelial cells. | Q44565932 |
| | Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults | Q44909536 |
| | Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization | Q44965912 |
| | Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) | Q45071059 |
| | Hypoadiponectinemia is associated with ischemic cerebrovascular disease | Q45251436 |
| | Prevalence of dementia after age 90: results from the 90+ study. | Q46067321 |
| | Adipocytokines and risk of stroke in older people: a nested case-control study | Q46295029 |
| | Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men. | Q46368034 |
| | Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner | Q46644037 |
| | Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study | Q46666294 |
| | Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. | Q46680003 |
| | Pulse pressure correlates with leukoaraiosis in Alzheimer disease. | Q46684203 |
| | Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells | Q46759092 |
| | Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging | Q46799368 |
| | Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria | Q46927442 |
| | Intranasal insulin improves cognition and modulates beta-amyloid in early AD. | Q46945303 |
| | AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress | Q47858200 |
| | Adipocytokines and the risk of ischemic stroke: the PRIME Study | Q47872910 |
| | Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake | Q48111745 |
| | Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 |
| | Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 |
| | Alzheimer disease: caused by primary deficiency of the cerebral blood flow | Q48438871 |
| | Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study | Q48874950 |
| | Adipocytokines and ischemic stroke: differential associations between stroke subtypes | Q48932860 |
| | AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle | Q34406367 |
| | Elevated pulse pressure is associated with age-related decline in language ability | Q34433705 |
| | Poststroke dementia. | Q34461454 |
| | Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine | Q34474707 |
| | Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease | Q34479731 |
| | Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells | Q34479930 |
| | Hypertension and diabetes | Q34539880 |
| | Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease | Q34592893 |
| | Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? | Q34669518 |
| | AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies | Q34696305 |
| | Does insulin dysfunction play a role in Alzheimer's disease? | Q34708071 |
| | Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women | Q34819729 |
| | Protecting against vascular disease in brain | Q34979773 |
| | The role of adiponectin in secondary inflammatory reaction in cerebral ischemia | Q35027994 |
| | Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies | Q35120070 |
| | Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha | Q35209149 |
| | Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin | Q35218879 |
| | Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells | Q35218922 |
| | Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study | Q35225442 |
| | Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies | Q35231770 |
| | Implications of plasma concentrations of adiponectin in patients with coronary artery disease | Q35582303 |
| | Insulin receptor and ageing | Q35586455 |
| | Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors | Q35606711 |
| | Adiponectin: A novel adipokine linking adipocytes and vascular function | Q35794441 |
| | Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. | Q35846048 |
| | Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians | Q35994678 |
| | Adiponectin: action, regulation and association to insulin sensitivity | Q36011919 |
| | The role of insulin receptor signaling in the brain | Q36056044 |
| | Insulin resistance in the nervous system | Q36084516 |
| | Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy | Q36136280 |
| | The age-dependent relation of blood pressure to cognitive function and dementia | Q36201875 |
| | Impact of metabolic syndrome on cognition and brain: a selected review of the literature | Q36233972 |
| | The impact of recurrent hypoglycemia on cognitive function in aging | Q36291139 |
| | Adiponectin: a key adipocytokine in metabolic syndrome | Q36389747 |
| | Periadventitial adipose tissue plays a critical role in vascular remodeling. | Q50582947 |
| | Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. | Q50917866 |
| | Globular adiponectin induces LKB1/AMPK-dependent glucose uptake via actin cytoskeleton remodeling. | Q50958608 |
| | Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. | Q51046495 |
| | Effects of resistance versus endurance training on serum adiponectin and insulin resistance index. | Q51460327 |
| | Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. | Q51486788 |
| | Adipocytokines, fat distribution, and insulin resistance in elderly men and women. | Q51526925 |
| | Hypoadiponectinemia is closely linked to endothelial dysfunction in man. | Q51535575 |
| | Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. | Q51540486 |
| | Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. | Q51555890 |
| | Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. | Q51559492 |
| | Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. | Q51561458 |
| | Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. | Q51575696 |
| | Longitudinal associations between blood pressure and dementia in the very old. | Q51660408 |
| | Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. | Q51950050 |
| | Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. | Q51969591 |
| | Intracerebroventricular insulin enhances memory in a passive-avoidance task. | Q52028440 |
| | Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. | Q52570216 |
| | Midlife blood pressure and dementia: the Honolulu-Asia aging study. | Q53234678 |
| | Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. | Q53261918 |
| | Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. | Q53281587 |
| | Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. | Q53389940 |
| | Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. | Q53631333 |
| | Reduced longevity in untreated patients with isolated growth hormone deficiency. | Q53920851 |
| | Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. | Q53981339 |
| | Vascular dementia | Q56005420 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular dementia | Q583908 |
| | complications of diabetes mellitus | Q4198677 |
| | stroke | Q12202 |
| | adiponectin | Q103840042 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 261672 | |
| P577 | publication date | 2014-04-17 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Association between risk factors for vascular dementia and adiponectin | |
| P478 | volume | 2014 | |